Ro 07-1902

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 526136

CAS#: 526136

Description: Ro 07-1902 enhances the effect of specific antineoplastic agents.

Chemical Structure

img
Ro 07-1902
CAS# 526136
Instruction

Theoretical Analysis

MedKoo Cat#: 526136
Name: Ro 07-1902
CAS#: 526136
Chemical Formula: C9H13N3O4
Exact Mass: 227.09
Molecular Weight: 227.220
Elemental Analysis: C, 47.57; H, 5.77; N, 18.49; O, 28.16

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Ro 07-1902; Ro-07-1902; Ro07-1902.

IUPAC/Chemical Name: 2-Nitro-alpha-((1-propenyloxy)methyl)imidazole-1-ethanol

InChi Key: XVAVDAAXADYTPR-GORDUTHDSA-N

InChi Code: InChI=1S/C9H13N3O4/c1-2-5-16-7-8(13)6-11-4-3-10-9(11)12(14)15/h2-5,8,13H,6-7H2,1H3/b5-2+

SMILES Code: OC(CO/C=C/C)CN1C=CN=C1[N+]([O-])=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 227.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Lee FY, Workman P. Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studies. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1383-7. PubMed PMID: 3759560.

2: Chaplin DJ, Sheldon PW, Ahmed I, Adams GE. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles. Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1647-51. PubMed PMID: 6480452.

3: Lee FY, Workman P. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics. Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1627-30. PubMed PMID: 6237080.

4: Twentyman PR, Workman P. Chemosensitization by lipophilic nitroimidazoles. Br J Cancer. 1983 Jul;48(1):17-26. PubMed PMID: 6871076; PubMed Central PMCID: PMC2011422.

5: Workman P, Twentyman PR. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. Br J Cancer. 1982 Aug;46(2):249-59. PubMed PMID: 7150475; PubMed Central PMCID: PMC2011106.

6: Workman P, Twentyman PR. Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):623-6. PubMed PMID: 7107385.

7: Twentyman PR, Workman P. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):611-3. PubMed PMID: 7107382.